SCHEMBL16484335

SCHEMBL16484335

c1ccc(-c2ccc3c(c2)c2c(ccc4c5ccc6c(c7ccccc7n6-c6ccccc6)c5n(-c5ccccc5)c42)n3-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ATM Q13315 1/20 0.47
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
KMT2A Q03164 3/20 0.38
IL1R1 P14778 1/20 0.38
TSPO P30536 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
HDAC4 P56524 1/20 0.34
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
BRCA1 P38398 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAOB P27338 1/20 0.33
NR3C1 P04150 1/20 0.33
AVPR1A P37288 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17108994 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL16484334 0.94 L3MBTL1 (0.51) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL23008358 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL23008274 0.93 L3MBTL1 (0.46) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL23008169 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL16484405 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL27426974 0.93 L3MBTL1 (0.52) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL19652715 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL19863533 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL17759995 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021037401-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-03-04 WO disclosed
WO-2020127165-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-06-25 WO disclosed
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 US disclosed
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 US disclosed
WO-2014057684-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME 出光興産株式会社 (JP) 2014-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME YBX1, ATXN2L, ATXN2 L3MBTL1 106/4885KDM4E 2405/4885ATM 3393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.